Company: SWKH
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050155
Chunk: 102

Company: SWK Holdings Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 2
Chunk 102
---
Relief (6)Rare Disease Portfolio7,701 — — 336 Best ABT, Inc.(2), (3)Oncology diagnosis 5,784 2,347 — — Flowonix Medical, Inc.(2), (3), (4)Drug delivery device 12,455 6,633 — — Ideal Implant, Inc.(2), (3)Aesthetics 4,025 2,522 — — Iluvien® (7)Diabetic macular edema16,501 — — 519 Revenue RecognizedTerm LoansTypeMaturity DatePrincipalGAAP BalanceRateQ3 2025Year-to-Date4Web, Inc.First lien12/31/27$19,486 $23,037 12.8%$1,226 $3,083 AOTI, Inc.First lien02/15/2919,478 19,623 13.0%658 1,411 Elutia, Inc.First lien08/10/2722,074 27,372 11.0%2,335 4,161 Biotricity, Inc.First lien02/15/2713,846 14,413 11.5%660 2,004 CDMO ManufacturerFirst lien09/13/275,000 5,491 13.3%205 599 eTon Pharmaceuticals, Inc.First lien12/17/2730,000 29,644 11.8%1,156 3,391 Journey Medical CorporationFirst lien12/27/2725,000 25,213 12.8%925 2,742 MedMinder Systems, Inc.First lien08/18/2822,500 22,987 12.3%814 2,406 MolecuLight, Inc.(7)First lien12/29/27— — 12.8%— 27 Nicoya Lifesciences, Inc.First lien11/30/268,500 8,846 12.8%390 954 NeoLight, LLCFirst lien05/15/275,553 5,923 13.5%224 681 Shield Therapeutics, PlcFirst lien09/28/2820,000 20,033 14.3%865 2,533 SKNV